Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Publications indexed to the term Carcinoma, Hepatocellular

FacultyTitle
1Targeted degradation of GOLM1 by CC-885 via CRL4-CRBN E3 ligase inhibits hepatocellular carcinoma progression. (He J, Guo J, Liu S, Li H, Ma Y, Ma S, Hu Z, Zhao W, Tan M, Liu W, Liu B) Cell Signal 2025 Jun;130:111665    
1Identification of MORF4L1 as an endogenous substrate of CRBN and its potential role as a therapeutic target in cancer. (Zhang L, Liu S, He J, Hu Z, Zhu L, Huang H, Gao Q, Wang D, Chen L, Zhang X, Liu R, Wang J, Song Y, Zeng K, Li X, Chen Y, Zou X, Ma S, Wang X, Xu G, Liu W, Liu B) Sci Rep 2025 Jan 18;15(1):2384       1 Citation
1Analgesic effects of ultrasound-guided preoperative posterior Quadratus Lumborum block in laparoscopic hepatectomy: A prospective double-blinded randomized controlled trial. (Lee S, Ko JS, Kang R, Choi GS, Kim JM, Gwak MS, Shin YH, Lee SM, Kim GS) J Clin Anesth 2024 Oct;97:111504    
1Combination and Optimal Sequencing of Systemic and Locoregional Therapies in Hepatocellular Carcinoma: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel. (Thornton LM, Abi-Jaoudeh N, Lim HJ, Malagari K, Spieler BO, Kudo M, Finn RS, Lencioni R, White SB, Kokabi N, Jeyarajah DR, Chaudhury P, Liu D) J Vasc Interv Radiol 2024 Jun;35(6):818-824       2 Citations
1Molecularly generated rat hepatitis E virus strains from human and rat show efficient replication in a human hepatoma cell line. (Panajotov J, Falkenhagen A, Gadicherla AK, Johne R) Virus Res 2024 Jun;344:199364       3 Citations
1DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma. (Kirk AM, Crawford JC, Chou CH, Guy C, Pandey K, Kozlik T, Shah RK, Chung S, Nguyen P, Zhang X, Wang J, Bell M, Mettelman RC, Allen EK, Pogorelyy MV, Kim H, Minervina AA, Awad W, Bajracharya R, White T, Long D Jr, Gordon B, Morrison M, Glazer ES, Murphy AJ, Jiang Y, Fitzpatrick EA, Yarchoan M, Sethupathy P, Croft NP, Purcell AW, Federico SM, Stewart E, Gottschalk S, Zamora AE, DeRenzo C, Strome SE, Thomas PG) Cell Rep Med 2024 Mar 19;5(3):101469       4 Citations
1Clinical Outcomes After Personalized Dosimetry for 90Y Radioembolization of Advanced Hepatocellular Carcinoma: Defining the Role of a Device in a Pharma-Centric Landscape. (Soulen MC, Rilling WS) J Nucl Med 2024 Feb 01;65(2):270-271       2 Citations
1Hepatocellular carcinoma in survivors after Fontan operation: a case-control study. (Kim YY, Lluri G, Haeffele C, Daugherty T, Krasuski RA, Serfas JD, de Freitas RA, Porlier A, Lubert AM, Wu FM, Valente AM, Krieger EV, Buber J, Rodriguez FH 3rd, Gaignard S, Saraf A, Hindes M, Earing MG, Lewis MJ, Rosenbaum MS, Zaidi AN, Hopkins K, Bradley EA, Cedars AM, Ko JL, Franklin WJ, Frederickson A, Ginde S, Grewal J, Nyman A, Min J, Schluger C, Rand E, Rosenthal BE, Hilscher M, Rychik J, Hoteit MA) Eur Heart J 2024 Apr 21;45(16):1477-1480       11 Citations
1Increased liver stiffness promotes hepatitis B progression by impairing innate immunity in CCl4-induced fibrotic HBV+ transgenic mice. (Bybee G, Moeun Y, Wang W, Kharbanda KK, Poluektova LY, Kidambi S, Osna NA, Ganesan M) Front Immunol 2023;14:1166171       6 Citations
2Risk of Hepatic Artery Complications After Liver Transplantation in Patients Who Received Pretransplant Transarterial Chemoembolization Therapy: A Single-Center Experience. (Selim M, Hohenwalter EJ, Rilling WS, Hong JC) Transplant Proc 2023 Sep;55(7):1631-1637       2 Citations
2Chemical Shift MRI Monitoring of Chemoembolization Delivery for Hepatocellular Carcinoma: Multicenter Feasibility of Initial Clinical Translation. (Gordon AC, Lewandowski RJ, Li W, Zhong X, Kannengiesser SAR, Miller FH, Salem R, Rilling WS, Larson AC, White SB) Radiol Imaging Cancer 2023 May;5(3):e220019    
1AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. (Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, Jou JH, Kulik LM, Agopian VG, Marrero JA, Mendiratta-Lala M, Brown DB, Rilling WS, Goyal L, Wei AC, Taddei TH) Hepatology 2023 Dec 01;78(6):1922-1965       755 Citations
1Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion. (Kothari AN, Massarweh NN, Flitcroft MA, Newhook T, Tzeng CD, Chun YS, Kaseb AO, Vauthey JN, Tran Cao HS) HPB (Oxford) 2023 Jul;25(7):758-765       4 Citations
1Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab. (Berger R, Dinstag G, Tirosh O, Schiff E, Kleiner D, Aldape KD, Ruppin E, Beker T, Kurzrock R) J Immunother Cancer 2022 Dec;10(12)       12 Citations
1Correlation of Non-tumoral Liver Dose with Treatment-Related Adverse Events in Patients with Hepatocellular Carcinoma Treated with Glass-Based Yttrium-90 Radioembolization. (Webster LA, Villalobos A, Cheng B, Xing M, Majdalany BS, Bercu ZL, Cristescu MM, Brandon D, Schuster D, Baum Y, Loya MF, Kokabi N) Cardiovasc Intervent Radiol 2023 Jan;46(1):60-68       2 Citations
1ACR Appropriateness Criteria® Management of Liver Cancer: 2022 Update. (Expert Panel on Interventional Radiology, Knavel Koepsel EM, Smolock AR, Pinchot JW, Kim CY, Ahmed O, Chamarthy MRK, Hecht EM, Hwang GL, Kaplan DE, Luh JY, Marrero JA, Monroe EJ, Poultsides GA, Scheidt MJ, Hohenwalter EJ) J Am Coll Radiol 2022 Nov;19(11S):S390-S408       2 Citations
1Robotic liver resection for hepatic cyst using indocyanine-green fluorescence imaging. (Takagi K, Umeda Y, Kimura J, Yagi T) Asian J Surg 2023 Apr;46(4):1839-1841    
1Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma. (Juloori A, Katipally RR, Lemons JM, Singh AK, Iyer R, Robbins JR, George B, Hall WA, Pitroda SP, Arif F, Fung J, Pillai A, Liao CY, Sharma M, Liauw SL) Int J Radiat Oncol Biol Phys 2023 Jan 01;115(1):202-213       46 Citations
1Microwave Ablation as Bridging to Liver Transplant for Patients with Hepatocellular Carcinoma: A Single-Center Retrospective Analysis. (Couillard AB, Knott EA, Zlevor AM, Mezrich JD, Cristescu MM, Agarwal P, Ziemlewicz TJ, Longhurst C, Lubner MG, Hinshaw JL, Said A, Laeseke PF, Lucey MR, Rice JP, Foley D, Al-Adra D, Lee FT Jr) J Vasc Interv Radiol 2022 Sep;33(9):1045-1053       12 Citations
1Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study. (Short SS, Kastenberg ZJ, Wei G, Bondoc A, Dasgupta R, Tiao GM, Watters E, Heaton TE, Lotakis D, La Quaglia MP, Murphy AJ, Davidoff AM, Mansfield SA, Langham MR, Lautz TB, Superina RA, Ott KC, Malek MM, Morgan KM, Kim ES, Zamora A, Lascano D, Roach J, Murphy JT, Rothstein DH, Vasudevan SA, Whitlock R, Lal DR, Hallis B, Bütter A, Baertschiger RM, Lapidus-Krol E, Putra J, Tracy ER, Aldrink JH, Apfeld J, Le HD, Park KY, Rich BS, Glick RD, Fialkowski EA, Utria AF, Meyers RL, Riehle KJ) Cancer 2022 Jul 15;128(14):2786-2795       11 Citations
1The Immune Response: A New Frontier in Interventional Oncology. (White SB) Radiology 2022 Apr;303(1):229-230    
1Palliative radiation for bone metastases from hepatocellular carcinoma: practice patterns and the amount of remaining life spent receiving treatment. (Schmid RK, Johnstone CA, Robbins JR) Ann Palliat Med 2022 Jun;11(6):1900-1910       2 Citations
1Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma: Experience from the Society of Pediatric Liver Transplantation (SPLIT). (Boster JM, Superina R, Mazariegos GV, Tiao GM, Roach JP, Lovell MA, Greffe BS, Yanni G, Leung DH, Elisofon SA, McDiarmid SV, Gupta NA, Lobritto SJ, Lemoine C, Stoll JM, Vitola BE, Daniel JF, Sayed BA, Desai DM, Martin AE, Amin A, Anand R, Anderson SG, Sundaram SS) Am J Transplant 2022 May;22(5):1396-1408       30 Citations
1Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma. (Villalobos A, Wagstaff W, Guo M, Zhang J, Bercu Z, Whitmore MJ, Cristescu MM, Majdalany BS, Wedd J, Akce M, Magliocca J, Kokabi N) Can J Gastroenterol Hepatol 2021;2021:9926704       7 Citations
1Computed Tomography Techniques, Protocols, Advancements, and Future Directions in Liver Diseases. (Kulkarni NM, Fung A, Kambadakone AR, Yeh BM) Magn Reson Imaging Clin N Am 2021 Aug;29(3):305-320       37 Citations
1Blood Salvage and Autotransfusion With Single Leukoreduction Does Not Increase the Risk of Tumor Recurrence After Liver Transplantation for Advanced Hepatocellular Carcinoma. (Kwon JH, Han S, Kim D, Kuk JH, Cho H, Kim S, Yang JD, Kim C, Kim JM, Choi GS, Joh JW, Ko JS, Gwak MS, Kim G) Ann Surg 2022 Dec 01;276(6):e842-e850       12 Citations
1Identification of a new TRAF6 inhibitor for the treatment of hepatocellular carcinoma. (Li N, Luo L, Wei J, Liu Y, Haque N, Huang H, Qi Y, Huang Z) Int J Biol Macromol 2021 Jul 01;182:910-920       10 Citations
1Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion. (Chen Y, Xia Y, Tolat PP, Long L, Jiang Z, Huang Z, Tang Q) AJR Am J Roentgenol 2021 Jun;216(6):1510-1520       30 Citations
1An invited commentary on "Anatomic versus non-anatomic resection for hepatocellular carcinoma, do we have an answer? A meta-analysis" [Int. J. Surg. (2020) Epub ahead of print]: Does liver anatomy matter? (Maduekwe UN, Charles A) Int J Surg 2020 Jul;79:326       2 Citations
1Yttrium-90 Radioembolization and Tumor Hypoxia: Gas-challenge BOLD Imaging in the VX2 Rabbit Model of Hepatocellular Carcinoma. (Gordon AC, White SB, Gates VL, Procissi D, Harris KR, Yang Y, Zhang Z, Li W, Lyu T, Huang X, Omary RA, Salem R, Lewandowski RJ, Larson AC) Acad Radiol 2021 Jun;28(6):849-858       7 Citations
1Decrease in the Risk of Posttransplant Hepatocellular Carcinoma Recurrence After the Conversion to Prestorage Leukoreduction for Transfused Red Blood Cells. (Kwon JH, Han S, Jang JS, Lee KW, Ahn JH, Kim K, Jeon S, Gwak MS, Ko JS, Kim GS, Joh JW, Cho D) Transplantation 2021 Mar 01;105(3):577-585       8 Citations
1Severe terminal ileitis induced by single-agent nivolumab administered every four weeks. (Dasanu CA, Plaxe SC, Gupta V, Popescu IM, Grover M, Alvarez-Argote J) J Oncol Pharm Pract 2020 Sep;26(6):1516-1519       3 Citations
1Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy. (Coon C, Berger N, Eastwood D, Tsai S, Christians K, Mogal H, Clarke C, Gamblin TC) Ann Surg Oncol 2020 Apr;27(4):1156-1163       8 Citations
1Living-donor liver transplantation following cardiopulmonary bypass: A case report. (Oh MS, Sung JM, Yeon HJ, Cho HJ, Ko JS, Kim GS, Lim H) Medicine (Baltimore) 2019 Sep;98(38):e17230       1 Citation
1Treatment of Hepatocellular Carcinoma: Time for a Paradigm Shift? (White SB) Radiology 2019 Sep;292(3):760-761       2 Citations
1Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA. (Kaseb AO, Sánchez NS, Sen S, Kelley RK, Tan B, Bocobo AG, Lim KH, Abdel-Wahab R, Uemura M, Pestana RC, Qiao W, Xiao L, Morris J, Amin HM, Hassan MM, Rashid A, Banks KC, Lanman RB, Talasaz A, Mills-Shaw KR, George B, Haque A, Raghav KPS, Wolff RA, Yao JC, Meric-Bernstam F, Ikeda S, Kurzrock R) Clin Cancer Res 2019 Oct 15;25(20):6107-6118       66 Citations
1Hepatocellular Carcinoma. (Duran SR, Jaquiss RDB) N Engl J Med 2019 Jul 04;381(1):e2       26 Citations
1Clinical efficacy of TACE combined with Apatinib in the treatment of advanced hepatocellular carcinoma. (Zhu Y, Feng B, Mei L, Sun R, Guo C, Zhu J) J BUON 2019;24(2):608-614       27 Citations
1A Logistic Regression Model for Noninvasive Prediction of AFP-Negative Hepatocellular Carcinoma. (Luo CL, Rong Y, Chen H, Zhang WW, Wu L, Wei D, Wei XQ, Mei LJ, Wang FB) Technol Cancer Res Treat 2019 Jan 01;18:1533033819846632       21 Citations
1Anti-CD24 Antibody-Nitric Oxide Conjugate Selectively and Potently Suppresses Hepatic Carcinoma. (Sun F, Wang Y, Luo X, Ma Z, Xu Y, Zhang X, Lv T, Zhang Y, Wang M, Huang Z, Zhang J) Cancer Res 2019 Jul 01;79(13):3395-3405       52 Citations
1Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival. (Robbins JR, Schmid RK, Hammad AY, Gamblin TC, Erickson BA) Cancer Med 2019 Mar;8(3):928-938       22 Citations
3Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma. (Silva JP, Maurina MN, Tsai S, Christians KK, Clarke CN, Mogal H, Saeian K, Gamblin TC) J Am Coll Surg 2019 Mar;228(3):245-254       8 Citations
1Hepatocellular Carcinoma After Fontan Operation: Multicenter Case Series. (Egbe AC, Poterucha JT, Warnes CA, Connolly HM, Baskar S, Ginde S, Clift P, Kogon B, Book WM, Walker N, Wagenaar L, Moe T, Oechslin E, Kay WA, Norris M, Gordon-Walker T, Dillman JR, Trout A, Anwar N, Hoskoppal A, Veldtman GR) Circulation 2018 Aug 14;138(7):746-748       87 Citations
1Primary peritoneal hepatoid adenocarcinoma: a diagnostic and therapeutic conundrum in patients with gastrointestinal bleeding. (Inayat F, Zafar F, Lodhi HT, Ullah W) BMJ Case Rep 2018 Sep 18;2018       1 Citation
1A retrospective analysis of re-exploration after living donor right lobe liver transplantation: incidence, causes, outcomes, and risk factors. (Park J, Choi GS, Gwak MS, Ko JS, Han B, Han S, Joh JW, Lee SK, Kim J, Kim GS) Transpl Int 2019 Feb;32(2):141-152       3 Citations
2Real time evaluation of tissue optical properties during thermal ablation of ex vivo liver tissues. (Nagarajan VK, Gogineni VR, White SB, Yu B) Int J Hyperthermia 2019 Jan 01;35(1):176-182       18 Citations
1Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria. (Kim YR, Park S, Han S, Ahn JH, Kim S, Sinn DH, Jeong WK, Ko JS, Gwak MS, Kim GS) Sci Rep 2018 May 08;8(1):7157       33 Citations
190Y Radioembolization for Hepatic Malignancy in Patients with Previous Biliary Intervention: Multicenter Analysis of Hepatobiliary Infections. (Devulapalli KK, Fidelman N, Soulen MC, Miller M, Johnson MS, Addo E, El-Haddad G, Nutting C, Morrison J, Farsad K, Lokken RP, Gaba RC, Fleming J, Brown DB, Kwan SW, Rose SC, Pennycooke KA, Liu DM, White SB, Gandhi R, Lazar AA, Kerlan RK Jr) Radiology 2018 Sep;288(3):774-781       27 Citations
1Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma. (Ikeda S, Tsigelny IF, Skjevik ÅA, Kono Y, Mendler M, Kuo A, Sicklick JK, Heestand G, Banks KC, Talasaz A, Lanman RB, Lippman S, Kurzrock R) Oncologist 2018 May;23(5):586-593       74 Citations
1Analysis of Tissue and Circulating Tumor DNA by Next-Generation Sequencing of Hepatocellular Carcinoma: Implications for Targeted Therapeutics. (Ikeda S, Lim JS, Kurzrock R) Mol Cancer Ther 2018 May;17(5):1114-1122       51 Citations
1P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts. (Dou C, Liu Z, Tu K, Zhang H, Chen C, Yaqoob U, Wang Y, Wen J, van Deursen J, Sicard D, Tschumperlin D, Zou H, Huang WC, Urrutia R, Shah VH, Kang N) Gastroenterology 2018 Jun;154(8):2209-2221.e14       180 Citations
1Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone. (Smolock AR, Cristescu MM, Hinshaw A, Woo KM, Wells SA, Ziemlewicz TJ, Lubner MG, Dalvie PS, Louis Hinshaw J, Brace CL, Ozkan OS, Lee FT Jr, Laeseke P) Abdom Radiol (NY) 2018 Sep;43(9):2497-2504       39 Citations
2The effect of prior upper abdominal surgery on outcomes after liver transplantation for hepatocellular carcinoma: An analysis of the database of the organ procurement transplant network. (Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC) Surgery 2018 May;163(5):1028-1034       11 Citations
1Assessment of Adherence to Baseline Quality Measures for Cirrhosis and the Impact of Performance Feedback in a Regional VA Medical Center. (Cahill JA, Rizvi S, Saeian K) Am J Med Qual 2018;33(3):262-268       8 Citations
1Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation. (Han S, Lee S, Yang JD, Leise MD, Ahn JH, Kim S, Jung K, Gwak MS, Kim GS, Ko JS) Liver Transpl 2018 Jan;24(1):44-55       28 Citations
1The biology of Hepatocellular carcinoma: implications for genomic and immune therapies. (Khemlina G, Ikeda S, Kurzrock R) Mol Cancer 2017 Aug 30;16(1):149       337 Citations
1Unconventional MAPK-GSK-3β Pathway Behind Atypical Epithelial-Mesenchymal Transition In Hepatocellular Carcinoma. (Parveen S, Vedagiri D, Nair HG, Parthasarathy H, Harshan KH) Sci Rep 2017 Aug 18;7(1):8842       4 Citations
2The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients. (Silva JP, Gorman RA, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC) J Surg Oncol 2017 Dec;116(7):831-840       30 Citations
1Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors. (Han S, Yang JD, Sinn DH, Kim JM, Choi GS, Jung G, Ahn JH, Kim S, Ko JS, Gwak MS, Kwon CHD, Leise MD, Gwak GY, Heimbach JK, Kim GS) Ann Surg 2018 Dec;268(6):1043-1050       22 Citations
1Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. (Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, Cancer Genome Atlas Research Network) Cell 2017 Jun 15;169(7):1327-1341.e23       1653 Citations
1Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. (Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, Phan AT, Hawk E, Javle M, Lee JS, Torres HA, Rashid A, Lenzi R, Hassabo HM, Abaza Y, Shalaby AS, Lacin S, Morris J, Patt YZ, Amos CI, Khaderi SA, Goss JA, Jalal PK, Kaseb AO) Clin Gastroenterol Hepatol 2017 Nov;15(11):1791-1799       96 Citations
3Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. (Silva JP, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, White S, Rilling W, Gamblin TC) HPB (Oxford) 2017 Aug;19(8):659-666       88 Citations
1Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo. (Ma Z, He H, Sun F, Xu Y, Huang X, Ma Y, Zhao H, Wang Y, Wang M, Zhang J) J Cancer Res Clin Oncol 2017 Oct;143(10):1929-1940       31 Citations
2External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database. (Berger NG, Tanious MN, Hammad AY, Miura JT, Mogal H, Clarke CN, Christians KK, Tsai S, Gamblin TC) J Surg Oncol 2017 Sep;116(3):307-312       17 Citations
1Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma. (Kent LN, Bae S, Tsai SY, Tang X, Srivastava A, Koivisto C, Martin CK, Ridolfi E, Miller GC, Zorko SM, Plevris E, Hadjiyannis Y, Perez M, Nolan E, Kladney R, Westendorp B, de Bruin A, Fernandez S, Rosol TJ, Pohar KS, Pipas JM, Leone G) J Clin Invest 2017 Mar 01;127(3):830-842       90 Citations
1Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation. (Goldberg D, Ditah IC, Saeian K, Lalehzari M, Aronsohn A, Gorospe EC, Charlton M) Gastroenterology 2017 Apr;152(5):1090-1099.e1       462 Citations
1Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database. (Hammad AY, Robbins JR, Turaga KK, Christians KK, Gamblin TC, Johnston FM) Ann Palliat Med 2017 Jan;6(1):26-35       20 Citations
1Primary liver resection for patients with cirrhosis and hepatocellular carcinoma: the role of surgery in BCLC early (A) and intermediate stages (B). (Bell R, Pandanaboyana S, Lodge JPA, Prasad KR, Jones R, Hidalgo E) Langenbecks Arch Surg 2017 Jun;402(4):575-583       9 Citations
2E2f8 mediates tumor suppression in postnatal liver development. (Kent LN, Rakijas JB, Pandit SK, Westendorp B, Chen HZ, Huntington JT, Tang X, Bae S, Srivastava A, Senapati S, Koivisto C, Martin CK, Cuitino MC, Perez M, Clouse JM, Chokshi V, Shinde N, Kladney R, Sun D, Perez-Castro A, Matondo RB, Nantasanti S, Mokry M, Huang K, Machiraju R, Fernandez S, Rosol TJ, Coppola V, Pohar KS, Pipas JM, Schmidt CR, de Bruin A, Leone G) J Clin Invest 2016 Aug 01;126(8):2955-69       77 Citations
1Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence. (Han S, Yang JD, Sinn DH, Ko JS, Kim JM, Shin JC, Son HJ, Gwak MS, Joh JW, Kim GS) Transplantation 2016 Sep;100(9):1933-8       9 Citations
1Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems. (Sclair SN, Carrasquillo O, Czul F, Trivella JP, Li H, Jeffers L, Martin P) Dig Dis Sci 2016 Oct;61(10):2857-2867       18 Citations
1Efficacy and cost of robotic hepatectomy: is the robot cost-prohibitive? (Sham JG, Richards MK, Seo YD, Pillarisetty VG, Yeung RS, Park JO) J Robot Surg 2016 Dec;10(4):307-313       73 Citations
1A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma. (Wang T, Sun F, Xie W, Tang M, He H, Jia X, Tian X, Wang M, Zhang J) Cancer Lett 2016 Mar 28;372(2):166-78       46 Citations
1Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data. (Lencioni R, de Baere T, Soulen MC, Rilling WS, Geschwind JF) Hepatology 2016 Jul;64(1):106-16       594 Citations
1Clinical outcomes of left hepatic trisectionectomy for hepatobiliary malignancy. (Farid SG, White A, Khan N, Toogood GJ, Prasad KR, Lodge JP) Br J Surg 2016 Feb;103(3):249-56       20 Citations
1The Spectrum of E2F in Liver Disease--Mediated Regulation in Biology and Cancer. (Huntington JT, Tang X, Kent LN, Schmidt CR, Leone G) J Cell Physiol 2016 Jul;231(7):1438-49       11 Citations
1A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. (Zhu P, Jin J, Liao Y, Li J, Yu XZ, Liao W, He S) Oncotarget 2015 Dec 01;6(38):41383-97       32 Citations
1Safety of the Use of Blood Salvage and Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma. (Han S, Kim G, Ko JS, Sinn DH, Yang JD, Joh JW, Lee SK, Gwak MS) Ann Surg 2016 Aug;264(2):339-43       58 Citations
1Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion. (de Baere T, Arai Y, Lencioni R, Geschwind JF, Rilling W, Salem R, Matsui O, Soulen MC) Cardiovasc Intervent Radiol 2016 Mar;39(3):334-43       228 Citations
1Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma. (Park YY, Sohn BH, Johnson RL, Kang MH, Kim SB, Shim JJ, Mangala LS, Kim JH, Yoo JE, Rodriguez-Aguayo C, Pradeep S, Hwang JE, Jang HJ, Lee HS, Rupaimoole R, Lopez-Berestein G, Jeong W, Park IS, Park YN, Sood AK, Mills GB, Lee JS) Hepatology 2016 Jan;63(1):159-72       121 Citations
2Surgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysis. (Miura JT, Johnston FM, Tsai S, Eastwood D, Banerjee A, Christians KK, Turaga KK, Gamblin TC) HPB (Oxford) 2015 Oct;17(10):896-901       37 Citations
1Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma. (Zapf MA, Kothari AN, Weber CE, Arffa ML, Wai PY, Driver J, Gupta GN, Kuo PC, Mi Z) Surgery 2015 Oct;158(4):1039-47; discussion 1047-8       15 Citations
1Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials. (Subbiah IM, Falchook GS, Kaseb AO, Hess KR, Tsimberidou AM, Fu S, Subbiah V, Hong DS, Naing A, Piha-Paul SA, Akmal O, Janku F, Kurzrock R) Oncotarget 2015 Sep 29;6(29):28453-62       13 Citations
5Safety and efficacy of transarterial chemoembolization in patients with transjugular intrahepatic portosystemic shunts. (Miura JT, Rilling WS, White SB, Hieb RA, Tutton SM, Patel PJ, Gamblin TC, Hohenwalter EJ) HPB (Oxford) 2015 Aug;17(8):707-12       13 Citations
1Percutaneous ultrasound guided implantation of VX2 for creation of a rabbit hepatic tumor model. (White SB, Chen J, Gordon AC, Harris KR, Nicolai JR, West DL, Larson AC) PLoS One 2015;10(4):e0123888       22 Citations
1Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. (Wen Y, Han J, Chen J, Dong J, Xia Y, Liu J, Jiang Y, Dai J, Lu J, Jin G, Han J, Wei Q, Shen H, Sun B, Hu Z) Int J Cancer 2015 Oct 01;137(7):1679-90       191 Citations
1Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. (Hassan MM, Abdel-Wahab R, Kaseb A, Shalaby A, Phan AT, El-Serag HB, Hawk E, Morris J, Singh Raghav KP, Lee JS, Vauthey JN, Bortus G, Torres HA, Amos CI, Wolff RA, Li D) Gastroenterology 2015 Jul;149(1):119-29       98 Citations
1Performance Feedback Improves Compliance With Quality Measures. (Loy V, Kwiatt J, Dodda A, Martin E, Dua A, Saeian K) Am J Med Qual 2016;31(2):118-24       8 Citations
1Intraoperative hyperglycemia during liver resection: predictors and association with the extent of hepatocytes injury. (Han S, Ko JS, Jin SM, Park HW, Kim JM, Joh JW, Kim G, Choi SJ) PLoS One 2014;9(10):e109120       12 Citations
1Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replication. (Mukherjee S, Weiner WS, Schroeder CE, Simpson DS, Hanson AM, Sweeney NL, Marvin RK, Ndjomou J, Kolli R, Isailovic D, Schoenen FJ, Frick DN) ACS Chem Biol 2014 Oct 17;9(10):2393-403       75 Citations
1Microwave ablation for hepatic malignancies: a call for standard reporting and outcomes. (North DA, Groeschl RT, Sindram D, Martinie JB, Iannitti DA, Bloomston M, Schmidt C, Rilling WS, Gamblin TC, Martin RC) Am J Surg 2014 Aug;208(2):284-94       33 Citations
1Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing. (Janku F, Kaseb AO, Tsimberidou AM, Wolff RA, Kurzrock R) Oncotarget 2014 May 30;5(10):3012-22       87 Citations
1Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer. (Xie K, Liu J, Chen J, Dong J, Ma H, Liu Y, Hu Z) Gene 2014 Jun 10;543(1):101-7       55 Citations
1Audio-visual biofeedback does not improve the reliability of target delineation using maximum intensity projection in 4-dimensional computed tomography radiation therapy planning. (Lu W, Neuner GA, George R, Wang Z, Sasor S, Huang X, Regine WF, Feigenberg SJ, D'Souza WD) Int J Radiat Oncol Biol Phys 2014 Jan 01;88(1):229-35       9 Citations
3Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective. (Sullivan KM, Groeschl RT, Turaga KK, Tsai S, Christians KK, White SB, Rilling WS, Pilgrim CH, Gamblin TC) J Surg Oncol 2014 Feb;109(2):95-7       38 Citations
2Microwave ablation for hepatic malignancies: a multiinstitutional analysis. (Groeschl RT, Pilgrim CH, Hanna EM, Simo KA, Swan RZ, Sindram D, Martinie JB, Iannitti DA, Bloomston M, Schmidt C, Khabiri H, Shirley LA, Martin RC, Tsai S, Turaga KK, Christians KK, Rilling WS, Gamblin TC) Ann Surg 2014 Jun;259(6):1195-200       221 Citations
2Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma. (Dilip A, Cheng G, Joseph J, Kunnimalaiyaan S, Kalyanaraman B, Kunnimalaiyaan M, Gamblin TC) Anticancer Drugs 2013 Oct;24(9):881-8       27 Citations
1Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survival. (Groeschl RT, Hong JC, Christians KK, Turaga KK, Tsai S, Pilgrim CH, Gamblin TC) HPB (Oxford) 2013 Oct;15(10):794-802       5 Citations
1The SPLIT research agenda 2013. (Alonso EM, Ng VL, Anand R, Anderson CD, Ekong UD, Fredericks EM, Furuya KN, Gupta NA, Lerret SM, Sundaram S, Tiao G, Studies of Pediatric Liver Transplantation (SPLIT) Research Group) Pediatr Transplant 2013 Aug;17(5):412-22       21 Citations
1Pre-liver transplant biopsy in hepatocellular carcinoma: a potential criterion for exclusion from transplantation? (Young RS, Aldiwani M, Hakeem AR, Nair A, Guthrie A, Wyatt J, Treanor D, Morris-Stiff G, Jones RL, Prasad KR) HPB (Oxford) 2013 Jun;15(6):418-27       12 Citations
1Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies. (El-Gazzaz G, Sourianarayanane A, Menon KV, Sanabria J, Hashimoto K, Quintini C, Kelly D, Eghtesad B, Miller C, Fung J, Aucejo F) Hepatobiliary Pancreat Dis Int 2013 Feb;12(1):34-41    
1Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles. (Padia SA, Shivaram G, Bastawrous S, Bhargava P, Vo NJ, Vaidya S, Valji K, Harris WP, Hippe DS, Kogut MJ) J Vasc Interv Radiol 2013 Mar;24(3):301-6       83 Citations
1HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells. (Florentin J, Aouar B, Dental C, Thumann C, Firaguay G, Gondois-Rey F, Soumelis V, Baumert TF, Nunès JA, Olive D, Hirsch I, Stranska R) Blood 2012 Nov 29;120(23):4544-51       53 Citations
1Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment. (Yaqoob U, Cao S, Shergill U, Jagavelu K, Geng Z, Yin M, de Assuncao TM, Cao Y, Szabolcs A, Thorgeirsson S, Schwartz M, Yang JD, Ehman R, Roberts L, Mukhopadhyay D, Shah VH) Cancer Res 2012 Aug 15;72(16):4047-59       120 Citations
1Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis. (Sourianarayanane A, El-Gazzaz G, Sanabria JR, Menon KV, Quintini C, Hashimoto K, Kelly D, Eghtesad B, Miller C, Fung J, Aucejo F) HPB (Oxford) 2012 May;14(5):325-32       15 Citations
1Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma. (Hakeem AR, Young RS, Marangoni G, Lodge JP, Prasad KR) Aliment Pharmacol Ther 2012 May;35(9):987-99       94 Citations
1Hepatocellular carcinoma within a noncirrhotic, nonfibrotic, seronegative liver: surgical approaches and outcomes. (Young AL, Adair R, Prasad KR, Toogood GJ, Lodge JP) J Am Coll Surg 2012 Feb;214(2):174-83       48 Citations
1Disposition of ultrasound sensitive polymeric drug carrier in a rat hepatocellular carcinoma model. (Cochran MC, Eisenbrey JR, Soulen MC, Schultz SM, Ouma RO, White SB, Furth EE, Wheatley MA) Acad Radiol 2011 Nov;18(11):1341-8       57 Citations
1Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement. (Prasad KR, Young RS, Burra P, Zheng SS, Mazzaferro V, Moon DB, Freeman RB) Liver Transpl 2011 Oct;17 Suppl 2:S81-9       50 Citations
1[Relationship between genetic polymorphism in microRNAs precursor and genetic predisposition of hepatocellular carcinoma]. (Zhang XW, Pan SD, Feng YL, Liu JB, Dong J, Zhang YX, Chen JG, Hu ZB, Shen HB) Zhonghua Yu Fang Yi Xue Za Zhi 2011 Mar;45(3):239-43       34 Citations
1Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST). (Jiang T, Kambadakone A, Kulkarni NM, Zhu AX, Sahani DV) Invest Radiol 2012 Jan;47(1):11-7       140 Citations
1Risk of perioperative transfusion in elective hepatectomy. (Cockbain AJ, Goldsmith PJ, Prasad KR) Ann Surg 2011 Mar;253(3):631; author reply 632    
1Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. (Mathur AK, Osborne NH, Lynch RJ, Ghaferi AA, Dimick JB, Sonnenday CJ) Arch Surg 2010 Dec;145(12):1158-63       130 Citations
3Longitudinal quality of life assessment of patients with hepatocellular carcinoma after primary transarterial chemoembolization. (Wible BC, Rilling WS, Drescher P, Hieb RA, Saeian K, Frangakis C, Chen Y, Eastwood D, Kim HS) J Vasc Interv Radiol 2010 Jul;21(7):1024-30       39 Citations
1Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement. (Tsimberidou AM, Moulder S, Fu S, Wen S, Naing A, Bedikian AY, Daring S, Uehara C, Ng C, Wallace M, Camacho L, Kurzrock R) Cancer Chemother Pharmacol 2010 Nov;66(6):1087-93       16 Citations
1Molecular determinants dictating cell surface expression of the human sodium-dependent vitamin C transporter-2 in human liver cells. (Subramanian VS, Marchant JS, Said HM) Am J Physiol Gastrointest Liver Physiol 2010 Feb;298(2):G267-74       18 Citations
1Optimal treatment for hepatocellular carcinoma in the cirrhotic liver. (White SA, Manas DM, Farid SG, Prasad KR) Ann R Coll Surg Engl 2009 Oct;91(7):545-50       1 Citation
1HPB multidisciplinary teams. (Morris-Stiff GJ, Farid S, Prasad KR) Eur J Surg Oncol 2010 Mar;36(3):329-30       1 Citation
1Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. (Meng Z, Yang P, Shen Y, Bei W, Zhang Y, Ge Y, Newman RA, Cohen L, Liu L, Thornton B, Chang DZ, Liao Z, Kurzrock R) Cancer 2009 Nov 15;115(22):5309-18       258 Citations
1Salvage transplantation for stage IVa hepatocellular carcinoma, what are the guidelines? (Goldsmith PJ, Toogood GJ, Lodge JP, Prasad KR) Clin Transplant 2009;23(5):581       1 Citation
2Extrapolation of normal tissue complication probability for different fractionations in liver irradiation. (Tai A, Erickson B, Li XA) Int J Radiat Oncol Biol Phys 2009 May 01;74(1):283-9       29 Citations
1Greater hemodynamic instability with histidine-tryptophan-ketoglutarate solution than University of Wisconsin solution during the reperfusion period in living donor liver transplantation. (Ko JS, Kim GS, Gwak MS, Yang M, Kim HK, Shin BS, Kim JK, Lee SK) Transplant Proc 2008 Dec;40(10):3308-10       25 Citations
1Surgical management of hepatocellular carcinoma: is the jury still out? (Morris-Stiff G, Gomez D, de Liguori Carino N, Prasad KR) Surg Oncol 2009 Dec;18(4):298-321       56 Citations
1Pigment epithelium-derived factor is an angiogenesis and lipid regulator that activates peroxisome proliferator-activated receptor alpha. (Chung C, Doll JA, Stellmach VM, Gonzales J, Surapureddi S, Cornwell M, Reddy JK, Crawford SE) Adv Exp Med Biol 2008;617:591-7       25 Citations
1C-reactive protein in liver cancer surgery. (Morris-Stiff G, Gomez D, Prasad KR) Eur J Surg Oncol 2008 Jul;34(7):727-9       74 Citations
1Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. (Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, Lodge JP, Prasad KR) World J Surg 2008 Aug;32(8):1757-62       357 Citations
1Biologic study of the effects of octreotide-LAR on growth hormone in unresectable and metastatic hepatocellular carcinoma. (Attia S, Holen KD, Thomas JP, Richie K, Dzelak T, Teeter K, Warren D, Bilger A, Fine J, Eickhoff J, Drinkwater N, Mulkerin D, Morgan-Meadows S) Clin Adv Hematol Oncol 2008 Jan;6(1):44-54       5 Citations
2Estimate of radiobiologic parameters from clinical data for biologically based treatment planning for liver irradiation. (Tai A, Erickson B, Khater KA, Li XA) Int J Radiat Oncol Biol Phys 2008 Mar 01;70(3):900-7       58 Citations
1Rescue from neonatal death in the murine model of hereditary tyrosinemia by glutathione monoethylester and vitamin C treatment. (Langlois C, Jorquera R, Orejuela D, Bergeron A, Finegold MJ, Rhead WJ, Tanguay RM) Mol Genet Metab 2008 Mar;93(3):306-13       7 Citations
1Large hepatocellular carcinoma: time to stop preoperative biopsy. (Young AL, Malik HZ, Abu-Hilal M, Guthrie JA, Wyatt J, Prasad KR, Toogood GJ, Lodge JP) J Am Coll Surg 2007 Sep;205(3):453-62       38 Citations
1Radioembolization with 90Y microspheres: angiographic and technical considerations. (Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA Jr, Kulik L, Geschwind JF, Murthy R, Rilling W, Liu D, Bester L, Bilbao JI, Kennedy AS, Omary RA, Salem R) Cardiovasc Intervent Radiol 2007;30(4):571-92       232 Citations
2Intracellular dissemination of peroxidative stress. Internalization, transport, and lethal targeting of a cholesterol hydroperoxide species by sterol carrier protein-2-overexpressing hepatoma cells. (Kriska T, Levchenko VV, Korytowski W, Atshaves BP, Schroeder F, Girotti AW) J Biol Chem 2006 Aug 18;281(33):23643-51       35 Citations
3Chemoembolization in patients at high risk: results and complications. (Kiely JM, Rilling WS, Touzios JG, Hieb RA, Franco J, Saeian K, Quebbeman EJ, Pitt HA) J Vasc Interv Radiol 2006 Jan;17(1):47-53       50 Citations
1Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma. (Liau KH, Ruo L, Shia J, Padela A, Gonen M, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, DeMatteo RP) Cancer 2005 Nov 01;104(9):1948-55       113 Citations
1Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. (Nishio H, Hidalgo E, Hamady ZZ, Ravindra KV, Kotru A, Dasgupta D, Al-Mukhtar A, Prasad KR, Toogood GJ, Lodge JP) Ann Surg 2005 Aug;242(2):267-75       73 Citations
1Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. (Ghaferi AA, Hutchins GM) J Thorac Cardiovasc Surg 2005 Jun;129(6):1348-52       302 Citations
2Expression of human factor VIII under control of the platelet-specific alphaIIb promoter in megakaryocytic cell line as well as storage together with VWF. (Shi Q, Wilcox DA, Fahs SA, Kroner PA, Montgomery RR) Mol Genet Metab 2003 May;79(1):25-33       45 Citations
1Hepatocellular carcinoma: obligation and opportunity for interventional radiology. (Geschwind JF, Rilling WS) J Vasc Interv Radiol 2002 Sep;13(9 Pt 2):S167       1 Citation
1Role of antiviral therapy in the prevention of hepatocellular carcinoma. (Franco J, Saeian K) J Vasc Interv Radiol 2002 Sep;13(9 Pt 2):S191-6       10 Citations
1Multidisciplinary management of hepatocellular carcinoma. (Rilling WS, Drooz A) J Vasc Interv Radiol 2002 Sep;13(9 Pt 2):S259-63       31 Citations
2Hepatocellular carcinoma: multimodality management. (Christians KK, Pitt HA, Rilling WS, Franco J, Quiroz FA, Adams MB, Wallace JR, Quebbeman EJ) Surgery 2001 Oct;130(4):554-9; discussion 559-60       25 Citations
1Cooperation of fibronectin with lysophosphatidic acid induces motility and transcellular migration of rat ascites hepatoma cells. (Ayaki M, Mukai M, Imamura F, Iwasaki T, Mammoto T, Shinkai K, Nakamura H, Akedo H) Biochim Biophys Acta 2000 Jan 10;1495(1):40-50       21 Citations
1Hepatocellular carcinoma after renal transplantation in the absence of cirrhosis or viral hepatitis: a case series. (Saeian K, Franco J, Komorowski RA, Adams MB) Liver Transpl Surg 1999 Jan;5(1):46-9       19 Citations
1Activation of protein kinase Calpha couples cell volume to membrane Cl- permeability in HTC hepatoma and Mz-ChA-1 cholangiocarcinoma cells. (Roman RM, Bodily KO, Wang Y, Raymond JR, Fitz JG) Hepatology 1998 Oct;28(4):1073-80       50 Citations
1Characterization of normal and malignant human hepatocytes by Raman microspectroscopy. (Hawi SR, Campbell WB, Kajdacsy-Balla A, Murphy R, Adar F, Nithipatikom K) Cancer Lett 1996 Dec 20;110(1-2):35-40       63 Citations
1Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells. (Verbsky JW, Bach EA, Fang YF, Yang L, Randolph DA, Fields LE) J Biol Chem 1996 Jun 14;271(24):13976-80       63 Citations
1Glycosylation structure and enzyme activity of lecithin:cholesterol acyltransferase from human plasma, HepG2 cells, and baculoviral and Chinese hamster ovary cell expression systems. (Miller KR, Wang J, Sorci-Thomas M, Anderson RA, Parks JS) J Lipid Res 1996 Mar;37(3):551-61       27 Citations
1Focal masses in cirrhotic liver: CT and MR imaging features. (Taylor AJ, Carmody TJ, Quiroz FA, Erickson SJ, Varma RR, Komorowski RA, Foley WD) AJR Am J Roentgenol 1994 Oct;163(4):857-62       22 Citations
1Dexamethasone increases apolipoprotein A-I concentrations in medium and apolipoprotein A-I mRNA abundance from Hep G2 cells. (Varma VK, Smith TK, Sorci-Thomas M, Ettinger WH Jr) Metabolism 1992 Oct;41(10):1075-80       18 Citations
1Hepatocellular carcinoma in hemophilia. (Colombo M, Mannucci PM, Brettler DB, Girolami A, Lian EC, Rodeghiero F, Scharrer I, Smith PS, White GC 2nd) Am J Hematol 1991 Aug;37(4):243-6       68 Citations
1Growth of group A rotaviruses in a human liver cell line. (Schwarz KB, Moore TJ, Willoughby RE Jr, Wee SB, Vonderfecht SL, Yolken RH) Hepatology 1990 Oct;12(4 Pt 1):638-43       15 Citations
1Regulation of the expression of the rat alcohol dehydrogenase gene by glucocorticoids. (Qulali M, Wolfla CE, Ross RA, Crabb DW) Prog Clin Biol Res 1989;290:143-53       1 Citation
1Deposition of histones onto replicating chromosomes. (Jackson V, Granner DK, Chalkley R) Proc Natl Acad Sci U S A 1975 Nov;72(11):4440-4       37 Citations
1Studies on highly metabolically active acetylation and phosphorylation of histones. (Jackson V, Shires A, Chalkley R, Granner DK) J Biol Chem 1975 Jul 10;250(13):4856-63       119 Citations
1Phosphorylation of the lysine-rich histones throughout the cell cycle. (Balhorn R, Jackson V, Granner D, Chalkey R) Biochemistry 1975 Jun 03;14(11):2504-11       53 Citations
1Separation of newly synthesized nucleohistone by equilibrium centrifugation in cesium chloride. (Jackson V, Chalkley R) Biochemistry 1974 Sep 10;13(19):3952-6       50 Citations